Physician profile
Christopher Mahida
NPI 1659752582
$25,867.18
in general payments reported to CMS, 2019-2025
34 companies · $12K in 2025
The $12K reported for 2025 was more than what 95% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $77.52 · 2021: $891 · 2022: $1,748 · 2023: $4,942 · 2024: $6,368 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18K · Travel and Lodging: $4,779.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18,371.99 |
| Travel and Lodging | $4,779.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Imperative Care, INC | $14,717.92 | 2023-2025 | Symphony Catheter, Prodigy Catheter, Zoom 88-T Large Distal Platform |
| Inari Medical, INC. | $2,494.29 | 2021-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abbott Laboratories | $2,074.44 | 2020-2025 | Cardiomems, 2nd Gen Centrimag Primary Console, Thoratec Heartmate 3 Lvas Implant Kit |
| Abiomed | $1,487.10 | 2022-2025 | Impella |
| Boston Scientific Corporation | $1,015.76 | 2021-2025 | Watchman Access System, Wolverine Coronary Cutting Balloon, Avvigo Guidance System |
| Shockwave Medical, INC | $426.52 | 2022-2025 | |
| Edwards Lifesciences Corporation | $331.36 | 2022-2025 | Sapien 3 Ultra Resilia |
| Novartis Pharmaceuticals Corporation | $329.99 | 2023-2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $315.35 | 2022-2024 | Lifevest |
| Truvic Medical, INC. | $283.61 | 2022 | |
| Medtronic, INC. | $269.95 | 2021-2023 | Onyx Frontier |
| Chiesi USA, INC. | $264.24 | 2021-2022 | |
| Angiodynamics, INC. | $260.23 | 2025 | Auryon Laser System 100-120 Vac, Alphavac |
| Janssen Pharmaceuticals, INC | $189.41 | 2022-2023 | Xarelto |
| Cvrx, INC. | $165.24 | 2023-2024 | Barostim Neo System |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $158.30 | 2023-2025 | Indigo System |
| Cardiovascular Systems INC. | $124.34 | 2021 | |
| Terumo Medical Corporation | $115.61 | 2024 | |
| Cardiva Medical, INC. | $97.55 | 2024-2025 | Optowire, Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Ethicon INC. | $95.13 | 2023 | Harmonic |
| Tactile Systems Technology INC | $87.69 | 2025 | Nimbl, Flexitouch Plus |
| Merck Sharp & Dohme LLC | $86.70 | 2022-2023 | Verquvo |
| Amgen INC. | $73.10 | 2022-2023 | Repatha |
| Pfizer INC. | $67.15 | 2022-2023 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $58.65 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $56.67 | 2020-2023 | Farxiga |
| Stryker Corporation | $49.86 | 2025 | Artix Mt, Flowtriever |
| Bayer Healthcare Pharmaceuticals INC. | $47.32 | 2023 | |
| Actelion Pharmaceuticals US, INC. | $32.83 | 2023 | Opsumit, Uptravi |
| Novo Nordisk INC | $30.93 | 2023 | Ozempic |
| Atricure, INC. | $20.77 | 2024 | |
| Lexicon Pharmaceuticals, INC. | $15.52 | 2023 | Inpefa |
| Philips North America LLC | $14.16 | 2024 | (Ck4) Mcot |
| Thrombolex, INC. | $9.49 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Mahida listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.